IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a modified, long-acting version of Insulin-like Growth Factor 1, created to offer prolonged activity and improved stability compared to the natural form. Through structural adjustments that reduce its interaction with inhibitory binding proteins, IGF-1 LR3 stays active in the bloodstream for much longer, enabling extended engagement with IGF-1 receptors. This leads to increased signaling related to cell growth, protein production, and nutrient utilization. Widely used in research settings, IGF-1 LR3 is appreciated for its strong anabolic and regenerative effects, making it a valuable compound in studies focused on muscle development, tissue repair, and metabolic processes.

​

In simpler terms, IGF-1 LR3 binds to IGF-1 receptors located on cells throughout the body, particularly in muscle tissue. It triggers signaling pathways that instruct cells to grow, divide, and repair. Because it remains active longer than standard IGF-1, it can be more effective at supporting sustained growth and recovery over time.